These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15916798)

  • 1. In reply to the letter from Drs. Krafft and Hess.
    Lavey RS
    Gynecol Oncol; 2005 Aug; 98(2):333-4. PubMed ID: 15916798
    [No Abstract]   [Full Text] [Related]  

  • 2. IV iron administration in a peritoneal dialysis clinic.
    Bush B
    Nephrol Nurs J; 2004; 31(4):447-8. PubMed ID: 15453239
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to: Lavey, RS et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IB-IVA carcinoma of the cervix: a Southwest Oncology Group Study. Gynecol. Oncol. 95 (2004) 145-151.
    Krafft A; Hess T
    Gynecol Oncol; 2005 Jun; 97(3):980. PubMed ID: 15944000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anemia in chronic inflammatory intestinal disease: an often underestimated problem].
    Dejaco C; Gasche C
    Dtsch Med Wochenschr; 2002 Apr; 127(15):805-8. PubMed ID: 11951139
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to the letter by Nicolas et al, BJH-2010-01422.
    Lee P
    Br J Haematol; 2011 Mar; 152(6):785-6. PubMed ID: 21275955
    [No Abstract]   [Full Text] [Related]  

  • 6. [Latest information on the treatment of uterine cervical cancer].
    Watanabe Y; Ueda H
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1377-82. PubMed ID: 12214464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
    Fischer MA; Morris CA; Winkelmayer WC; Avorn J
    Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaemia in the critically ill patient: monitoring of erythropoietin therapy.
    Thomas C; Wiesner C; Melchior SW; Thüroff JW
    BJU Int; 2006 Jun; 97(6):1161-4. PubMed ID: 16686704
    [No Abstract]   [Full Text] [Related]  

  • 9. Is EPO therapy able to correct iron deficiency anaemia caused by matriptase-2 deficiency?
    Nicolas G; Deschemin JC; Ramsay AJ; Mayeux P; Grandchamp B; Beaumont C; Velasco G; Vaulont S
    Br J Haematol; 2011 Feb; 152(4):498-500. PubMed ID: 21223251
    [No Abstract]   [Full Text] [Related]  

  • 10. Discrepancy between the percentage of hypochromic erythrocytes and the reticulocyte hemoglobin content in hemodialysis patients with recombinant human erythropoietin therapy.
    Asanuma M; Taguchi C; Uesaka H; Kumagai T; Seino K; Hosokawa H; Yamauchi F; Fujishima M; Murai K; Ishida Y
    Lab Hematol; 2005; 11(2):124-30. PubMed ID: 16024336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience in the treatment of iron deficiency anemia with ferro-folgamma].
    Nikitin EN; Krasnoperova OV; Nikitin IuE
    Klin Med (Mosk); 2009; 87(3):64-7. PubMed ID: 19469261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than a decade of experience and still no consensus: controversies in iron therapy.
    Besarab A
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S1-3. PubMed ID: 17699371
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant human erythropoietin in a triplet pregnancy: a case report.
    Lialios G; Kallitsaris A; Bourantas KL; Messinis IE
    J Reprod Med; 2005 Nov; 50(11):863-6. PubMed ID: 16419637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past, present, and future of chronic kidney disease anemia management in the United States.
    Wish JB
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):101-8. PubMed ID: 19233069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the editor: treatment of iron deficiency anemia.
    Ozsoylu S
    Pediatr Hematol Oncol; 2005; 22(7):645-6; author reply 647-8. PubMed ID: 16166057
    [No Abstract]   [Full Text] [Related]  

  • 16. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R; Kalantar-Zadeh K
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Parenteral Iron Therapy in Ambulatory Older Adults with Iron Deficiency Anaemia.
    Casteleyn I; Joosten E
    Acta Haematol; 2017; 138(4):221-222. PubMed ID: 29237150
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased importance of intravenous iron in chemotherapy-induced anemia.
    Auerbach M; Henry DH
    J Clin Oncol; 2007 May; 25(15):2145-6. PubMed ID: 17513828
    [No Abstract]   [Full Text] [Related]  

  • 20. Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications.
    Macdougall IC; Ashenden M
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):117-30. PubMed ID: 19233071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.